Drug and Therapeutics Committees - A Practical Guide
(2003; 155 pages) [French] [Spanish] Voir le document au format PDF
Table des matières
Afficher le documentAcronyms and abbreviations
Afficher le documentPreface
Ouvrir ce répertoire et afficher son contenu1. Introduction
Ouvrir ce répertoire et afficher son contenu2.Structure and organization of a drug and therapeutics committee
Ouvrir ce répertoire et afficher son contenu3. Managing the formulary process
Ouvrir ce répertoire et afficher son contenu4.Assessing new medicines
Fermer ce répertoire5.Ensuring medicine safety and quality
Afficher le document5.1 The need for ensuring medicine safety and quality
Afficher le document5.2 Monitoring and addressing medication errors
Afficher le document5.3 Monitoring and ensuring medicine quality
Afficher le document5.4 Safety of medicines
Afficher le documentAnnex 5.1 Basic analytical medicine tests
Afficher le documentAnnex 5.2 Examples of adverse drug reaction reporting (ADR) reporting forms
Afficher le documentAnnex 5.3 Naranjo algorithm for assessing the causality of an ADR
Ouvrir ce répertoire et afficher son contenu6.Tools to investigate the use of medicines
Ouvrir ce répertoire et afficher son contenu7.Promoting the rational use of medicines
Ouvrir ce répertoire et afficher son contenu8.Antimicrobials and injections
Ouvrir ce répertoire et afficher son contenu9. Getting started
Afficher le documentGlossary1
Afficher le documentReferences
Afficher le documentFurther reading
Afficher le documentUseful addresses and websites
Afficher le documentBack cover
 

5.Ensuring medicine safety and quality

Summary

A significant amount of harm to patients and wastage of resources is caused through the use of unsafe, poor-quality medicines. The DTC has a role to ensure that all medicines prescribed and dispensed to patients are safe and of good quality. This involves:

• monitoring and addressing medication errors

• ensuring medicine quality through ensuring good practices concerning procurement, storage and distribution and monitoring and addressing drug quality problems

• monitoring and addressing adverse drug reactions, which may be caused by the chemical entity itself or may be due to medication errors or poor drug quality.


These activities necessarily involve looking at the health system as a whole to identify practices and environmental problems that may be contributing to poor drug safety and quality.

vers la section précédente vers la section suivante
 

Dernière mise à jour: le 3 mai 2013